- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03428542
Yoga and Psychological and Physiological Health
The Effects of Yoga on Psychological and Physiological Health in a Population Based Cohort
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Stress and worry in everyday life are common features of Western society. Stress is a biological mechanism tapping the fight-or-flight-response via activation of the sympathetic nervous system. When exposed to stress during prolonged periods of time, the immune system is affected, leading to physiological as well as psychosocial problems. The consequences of untreated high stress can not only turn into reduced job capacity, and work roles conflicts, but also into cardiovascular disease, and mental illness such as an anxiety disorder or/and depression.
One common and recommended strategy to manage stress is to exercise regularly. Yoga is an umbrella term for a wide variety of physical, mental, and spiritual practices with its roots in ancient India. Most previous research on the health effects of yoga has demonstrated benefits on psychological health factors including mental stress, anxiety, depression and sleep problems.
The aim of the study is thus to investigate the effects of two types of yoga intervention on psychological and physiological health.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Malmö, Sweden, 20502
- KFE, Skåne University Hospital in Malmö
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A score on four items of the Perceived Stress Scale between 8-16, thereby indicating a current stress experience of at least moderate level.
- Ability to participate in the intervention during the time-period.
- Comprehensive in Swedish.
Exclusion Criteria:
- Ongoing yoga practice or any regular practice of yoga or meditation within the last 6 months.
- Any known physical limitations that may prevent light physical activity (yoga postures).
- Current psychological or psychopharmacological treatment.
- Inability to attend more than 5 of the scheduled 10 yoga sessions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control arm
Instructed not to practice any yoga or mindfulness during the five-week study period.
|
|
ACTIVE_COMPARATOR: Yin yoga intervention arm
The Yin yoga intervention arm will receive Yin yoga, a calm-paced practice that uses seated and lying down positions. Participants were also provided a CD which contained a 10-minute voice recording called conscious breathing. The guided instructions encouraged participants to keep awareness on their breath and to use calm, slow, nostril breathing. |
Yin yoga 2 times per week for 5 weeks.
Daily breathing assignments.
|
ACTIVE_COMPARATOR: YOMI program intervention arm
The YOMI intervention arm will receive stress education + yoga, and bring together education about stress, mindfulness and yoga practice. It will involve weekly group meetings, homework, and yoga postures. Stress education and mindfulness will make up one portion of the intervention. This will take place in a group lecture format and shall be conducted by a mental health professional(s). Yoga practice in a group format will make up the second portion of the intervention. Participants were also provided a CD which contained a 10-minute voice recording called conscious breathing. The guided instructions encouraged participants to keep awareness on their breath and to use calm, slow, nostril breathing. |
30 minutes of psychoeducation combined with mindfulness practice followed by 60 minutes of Yin yoga allowing the psychological theme to be further explored, aided by verbal instructions of the yoga teacher. 2 times per week for 5 weeks. Daily breathing assignments. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Stress Scale
Time Frame: 5 weeks
|
A 10-item scale measuring the degree to which situations in one's life are appraised as stressful.The items are rated on a 5-point scale from 0 (never) to 4 (very often).
Total scores range from 0 to 40, with higher scores indicating a higher stress level.
|
5 weeks
|
The Hospital Anxiety and Depression Scale
Time Frame: 5 weeks
|
A fourteen item scale which assesses levels of anxiety and depression.
Seven of the 14 items relate to anxiety and seven relate to depression.
Each item is scored from 0-3.
Items can be scored together by subscale (score range: 0-21), or for total scale score (score range: 0-42).
|
5 weeks
|
The COPE Inventory
Time Frame: 5 weeks
|
Assesses 14 conceptually distinct coping strategies.
It includes 13 scales with four items each and one single item question to assess different strategies for coping with stress.
All items are reported on a 4-point scale.
|
5 weeks
|
The Insomnia Severity Index
Time Frame: 5 weeks
|
A brief screening measure of insomnia and an outcome measure for use in intervention research.
The index contains seven items rated on a five-point Likert scale from 0 to 4. Higher scores indicate symptoms of insomnia.
|
5 weeks
|
Diet
Time Frame: 5 weeks
|
A 2-item measure that is used as an exploratory questionnaire.
The questions are as follows: Have you changed your eating habits since you started your participation in the study?
Categorical answer choices include 1) No, not at all, 2) Yes, to some extent, 3) Yes, to a great extent.
A second question is open-ended: If you have changed your eating habits, please describe how.
This very brief questionnaire will be given only once at the end of the study to explore whether dietary changes have occurred following the 5-week study period.
|
5 weeks
|
General Health Questionnaire
Time Frame: 5 weeks
|
Consists of 12 items, each one assessing the severity of a mental problem over the past few weeks using a 4-point Likert-type scale (from 0 to 3).
These scores generate a total score ranging from 0 to 36 where higher scores indicate worse health.
|
5 weeks
|
The Harmony in Life Scale
Time Frame: 5 weeks
|
Assesses a global sense of harmony in one's life and consists of 5 statements for which participants are asked to indicate degree of agreement on a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree).
The harmony score is established by summarizing the 5 statements for each participant, allowing for a maximum score of 35 (range: 5 - 35).
Higher scores represent greater harmony in life.
|
5 weeks
|
The Kentucky Inventory of Mindfulness Skills -Short Version
Time Frame: 5 weeks
|
A 20-item multi-dimensional scale of interrelated skills related to what one does while practicing mindfulness, and how one does it.
|
5 weeks
|
The Brief Experiential Avoidance Questionnaire
Time Frame: 5 weeks
|
A questionnaire which consists of 15 items used to assess behavioral avoidance , distress aversion, procrastination, distraction/suppression, repression/denial, and distress endurance.
Participants are asked to indicate degree of agreement on a 6-point Likert scale (1 = strongly disagree, 6 = strongly agree).
The score is established by summing all items (score range: 15 - 90).
|
5 weeks
|
The Self-Compassion Scale
Time Frame: 5 weeks
|
A 26-item measure with six subscales, tapping the construct of self-compassion.
The subscales are self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification.
Scores of subscales are added together for a total score representative of the level of self-compassion.
|
5 weeks
|
Fasting blood sampling
Time Frame: 5 weeks
|
A total of 3 tubes will be collected for each participant, amounting to a total of 65ml of blood per person.
Blood analysis will include stress hormones, inflammatory biomarkers, metabolic profiling, cardiometabolic biomarkers, cholesterol, triglycerides, creatinine, catecholamines (noradrenalin and adrenalin), renin, cortisol, and glucose concentration.
|
5 weeks
|
Fasting and 120-minute glucose tolerance test (mmol/L)
Time Frame: 5 weeks
|
The glucose tolerance test determines how the body responds to glucose (sugar).
After a fasting blood sample is taken (see above procedure), participants will be asked to drink a liquid containing glucose.
A second blood sample will be taken 120 minutes later.
|
5 weeks
|
Office and 24-hour blood pressure measurement (mmHg)
Time Frame: 5 weeks
|
Blood pressure measurements will be taken periodically by the device for a period of 24-hours.
|
5 weeks
|
Pulse-wave velocity
Time Frame: 5 weeks
|
Measured using a sphygmocor device.
|
5 weeks
|
Heart rate variability
Time Frame: 5 weeks
|
Measured with electrocardiogram during deep breathing.
Heart rate variability is is the variation in the time interval between heartbeats.
|
5 weeks
|
Gut microbiota
Time Frame: 5 weeks
|
Fecal samples.
|
5 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Olle Melander, MD, Prof., Lund University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015610
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Yin yoga
-
Chung Shan Medical UniversityCompleted
-
China Medical University HospitalChina Medical University, China; Chang Gung Memorial Hospital; National Research...Unknown
-
Chang Gung Memorial HospitalChina Medical University, China; China Medical University Hospital; National... and other collaboratorsUnknown
-
Shanghai Yueyang Integrated Medicine HospitalShanghai Skin Disease and Venereal Disease HospitalNot yet recruiting
-
Peking University Third HospitalChina Academy of Chinese Medical Sciences; Beijing University of Chinese Medicine and other collaboratorsRecruitingYin Deficiency SyndromeChina
-
Beijing Ditan HospitalCompletedHepatocellular CarcinomaChina
-
Beijing Ditan HospitalXiyuan Hospital of China Academy of Chinese Medical SciencesCompletedHepatocellular CarcinomaChina
-
Chung Shan Medical UniversityCompleted
-
Beijing Ditan HospitalActive, not recruiting
-
Shanghai University of Traditional Chinese MedicineMinistry of Science and Technology of the People´s Republic of ChinaUnknown